Emergent Biosolutions EBS Gain (Loss) on Disposition of Assets
Gain (Loss) on Disposition of Assets at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's gain (loss) on disposition of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's gain (loss) on disposition of assets?
- Emergent Biosolutions (EBS) reported gain (loss) on disposition of assets of -$800K in Q1 2026.
- How has Emergent Biosolutions's gain (loss) on disposition of assets changed year-over-year?
- Emergent Biosolutions's gain (loss) on disposition of assets decreased by 166.7% year-over-year, from -$300K to -$800K.
- What is the long-term trend for Emergent Biosolutions's gain (loss) on disposition of assets?
- Over 2 years (2022 to 2025), Emergent Biosolutions's gain (loss) on disposition of assets has grown at a 11.8% compound annual growth rate (CAGR), from -$3.6M to -$4.5M.